Parkinson Drugs Flashcards
1.5 modules away from spring break…
Just saying.
Levodopa/Carbidopa: class
Dopamine
Levodopa/Carbidopa: MOA
Increase dopamine levels in CNS
Levodopa/Carbidopa: indictaion
Parkinson’s disease
Levodopa/Carbidopa: side effects
Early: N/V, anorexia, HOTN
Late: Dyskinesia, sleep attacks
Levodopa/Carbidopa: contraindication
Renal/hepatic disease
More than 50% of Pts on Levodpa/Carbidopa develop…
Motor fluctuations and dyskinesia
Benztropine: class
Anticholinergic
Benztropine: MOA
Ach receptor inhibition
Benztropine: indication
PD, extrapyramidal sxs
Benztropine: side effects
Dry mouth, urinary retention, blurred vision, temp insensitivity
Benztropine: contraindication
Dementia, urinary retention, glaucoma
There’s good new and bad news about Benztropine. What is it?
Good new: it decreases drooling and tremors…
Bad news: it doesn’t really help with bradykinesia, rigidity, or gait disturbances
Amandatine: class
NMDA receptor antagonist
Amantadine: MOA
Decreases Levodopa injury to NMDA receptos
Amantadine: indictaion
Mild PD sxs
Amantadine: side effects
Livedo reticularis, peripheral edema, orthostatic HOTN
Amandtadine: contraindications
CKD
In what population should Amantadine be avoided?
The elderly
Eldepryl: class
MAO-B inhibitor
Eldepryl: MOA
Inhibition of MAO-B enzyme results in increased available dopamine in CNS
Eldepryl: indication
PD, depression
Eldepryl: side effects
Dyskinesia, confusion, hallucinations
Eldepryl: contraindication
Bipolar d/o, etoh